long term side effects of glp 1 medications The GLP-1 Trap: Your Jumpstart Might Be a Forever Commitment Press Release Page | Press

Lack of effect of the glucagon-like peptide-1 receptor agonist liraglutide on psoriasis in glucose-tolerant patients-a randomized placebo-controlled trial

Pierret ACS, Mizuno Y, Saunders P, Lim E, De Giorgi R, Howes OD, McCutcheon RA, McGowan B, Sen Gupta P, Smith D, Ismail K, Pillinger T (2025) Glucagon-Like Peptide 1 Receptor Agonists and Mental Health: A Systematic Review and Meta- Analysis

Key Takeaways Japans Ministry of Health, Labour and Welfare (MHLW) issued a formal appropriate-use notice on June 16, 2026 , targeting off-label cosmetic and weight-loss use of GLP-1 receptor agonists including Mounjaro, Ozempic, and Wegovy

This dual approach may result in a more pronounced reduction in appetite, aiding individuals in adhering to caloric restrictions and making healthier food choices

This is one of the most common questions I hear